Clinical Trial Update: Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing a new plant-based high-energy oral nutritional supplement for malnourished patients, with multiple listed conditions under study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chronic Obstructive Pulmonary Disease
• HIV Infection
• Inflammatory Bowel Diseases
• Malnutrition

Drugs mentioned

• plant-based high-energy oral nutritional supplement

Snippet

Sponsor: Danone Specialized Nutrition | Conditions: Malnutrition, Cancer | Phase 4 | Status: UNKNOWN